A
$ Value
$6K
Shares
29
Price
$207
Filed
May 7
Insider
Name
Byington Carrie L
Title
—
CIK
0001890265
Roles
Director
Transaction Details
Transaction Date
2025-05-06
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,588
Footnotes
The securities convert to common stock on a one-for-one basis. | The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. | Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.
Filing Info
Byington Carrie L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-04 | BDX | A | $6K |
| 2026-01-27 | BDX | A | $0 |
| 2025-11-04 | BDX | A | $6K |
| 2025-08-07 | BDX | A | $6K |
| 2025-05-06 | BDX | A | $6K |
Other Insiders at BDX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RING TIMOTHY M | — | — | 2026-01-27 |
| ECKERT R ANDREW | — | — | 2026-01-27 |
| SCOTT BERTRAM L | — | — | 2026-01-27 |
| HAYES GREGORY | — | — | 2026-01-27 |
| Jones Christopher Ian Montague | — | — | 2026-02-04 |
| Henderson Jeffrey William | — | — | 2026-01-27 |
| Brown William M | — | — | 2026-01-27 |
| Huffines Robert Luther | — | — | 2026-02-04 |
|
Neal Shana Carol
EVP and Chief People Officer
|
— | — | 2026-04-06 |
| Wright Jacqueline | — | — | 2026-01-27 |
| Byington Carrie L | — | — | 2026-02-04 |
| Waldstreicher Joanne | — | — | 2026-01-27 |
|
Feld Michael
EVP, CRO & Pres. Life Sciences
|
— | $15K | 2026-01-26 |
|
Feld Michael
EVP, Chief Revenue Officer
|
— | $12K | 2026-03-26 |